Table 3.
Group A (n=36) | Group B (n=23) | Survivors (n=61) | P value | P value |
|||
---|---|---|---|---|---|---|---|
Group A vs. Group B | Group A vs. Survivors | Group B vs. Survivors | |||||
CT (s) | |||||||
EXTEM | 89 [70–93] | 75 [67–84] | 70 [60–77] | <0.001 | 0.041 | <0.001 | 0.030 |
INTEM | 179 [153–193] | 174 [153–191] | 178 [160–193] | 0.750 | 1.000 | 1.000 | 1.000 |
CFT (s) | |||||||
EXTEM | 91 [71–106] | 83 [54–88] | 63 [53–76] | <0.001 | 0.020 | <0.001 | 0.030 |
INTEM | 75 [55–93] | 67 [50–82] | 66 [55–76] | 0.210 | 0.650 | 0.250 | 1.000 |
MCF (mm) | |||||||
EXTEM | 65 [58–74] | 66 [56–74 | 69 [65–75] | 0.019 | 1.000 | 0.060 | 0.044 |
INTEM | 64 [54–71] | 67 [56–73] | 67 [62–71] | 0.640 | 1.000 | 1.000 | 1.000 |
FIBTEM | 25 [16–41] | 26 [16–34] | 30 [22–39] | 0.130 | 1.000 | 0.480 | 0.160 |
TDI | |||||||
EXTEM | 0.42 [0.29–0.50] | 0.41 [0.3–0.55] | 0.49 [0.43–0.56] | 0.001 | 1.000 | 0.008 | 0.005 |
INTEM | 0.24 [0.18–0.32] | 0.27 [0.2–0.34] | 0.28 [0.23–0.33] | 0.340 | 0.900 | 0.450 | 1.000 |
Values are presented as median and [IQR]. CT: clotting time, CFT: clot formation time, MCF: maximum clot firmness, TDI: thrombodynamic index. Group A: non-survivors at 28 days, Group B: non-survivors between days 29 and 90 after enrollment.